Connection

Robert Gemmill to Humans

This is a "connection" page, showing publications Robert Gemmill has written about Humans.
Connection Strength

0.331
  1. The neuropilin 2 isoform NRP2b uniquely supports TGF?-mediated progression in lung cancer. Sci Signal. 2017 01 17; 10(462).
    View in: PubMed
    Score: 0.021
  2. Cholesterol and the development of clear-cell renal carcinoma. Curr Opin Pharmacol. 2012 Dec; 12(6):742-50.
    View in: PubMed
    Score: 0.016
  3. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011 Jan 01; 300(1):66-78.
    View in: PubMed
    Score: 0.014
  4. The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways. Mol Cancer Res. 2010 Jan; 8(1):93-106.
    View in: PubMed
    Score: 0.013
  5. Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC). Adv Cancer Res. 2010; 107:39-56.
    View in: PubMed
    Score: 0.013
  6. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. J Thorac Oncol. 2009 Dec; 4(12):1455-65.
    View in: PubMed
    Score: 0.013
  7. MYC and EIF3H Coamplification significantly improve response and survival of non-small cell lung cancer patients (NSCLC) treated with gefitinib. J Thorac Oncol. 2009 Apr; 4(4):472-8.
    View in: PubMed
    Score: 0.012
  8. RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene. Oncogene. 2007 Apr 05; 26(16):2263-71.
    View in: PubMed
    Score: 0.010
  9. Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma. Br J Cancer. 2005 Jun 20; 92(12):2266-77.
    View in: PubMed
    Score: 0.009
  10. Growth suppression induced by the TRC8 hereditary kidney cancer gene is dependent upon JAB1/CSN5. Oncogene. 2005 May 12; 24(21):3503-11.
    View in: PubMed
    Score: 0.009
  11. The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway. Oncogene. 2002 May 16; 21(22):3507-16.
    View in: PubMed
    Score: 0.008
  12. Isoforms of Neuropilin-2 Denote Unique Tumor-Associated Macrophages in Breast Cancer. Front Immunol. 2022; 13:830169.
    View in: PubMed
    Score: 0.008
  13. Pulsed-field gel electrophoresis for long-range restriction mapping. Curr Protoc Hum Genet. 2002 Feb; Chapter 5:Unit5.1.
    View in: PubMed
    Score: 0.007
  14. Purification and characterization of YACs containing large inserts. Curr Protoc Hum Genet. 2001 May; Chapter 5:Unit 5.7.
    View in: PubMed
    Score: 0.007
  15. Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2021 08; 162(2):463-473.
    View in: PubMed
    Score: 0.007
  16. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet. 2000 Feb; 117(1):9-18.
    View in: PubMed
    Score: 0.007
  17. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8. Proc Natl Acad Sci U S A. 1998 Aug 04; 95(16):9572-7.
    View in: PubMed
    Score: 0.006
  18. Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res. 1997 Apr 01; 57(7):1344-52.
    View in: PubMed
    Score: 0.005
  19. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS One. 2016; 11(1):e0147344.
    View in: PubMed
    Score: 0.005
  20. A second-generation YAC contig map of human chromosome 3. Nature. 1995 Sep 28; 377(6547 Suppl):299-319.
    View in: PubMed
    Score: 0.005
  21. YAC contigs covering an 8-megabase region of 3p deleted in the small-cell lung cancer cell line U2020. Genomics. 1995 Jan 01; 25(1):19-28.
    View in: PubMed
    Score: 0.005
  22. Dinucleotide repeat polymorphism (D3S1776) on human chromosome 3p. Hum Mol Genet. 1994 May; 3(5):841.
    View in: PubMed
    Score: 0.004
  23. Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation. Cancer Genet. 2014 Apr; 207(4):133-40.
    View in: PubMed
    Score: 0.004
  24. Neuropilin-2 Is upregulated in lung cancer cells during TGF-?1-induced epithelial-mesenchymal transition. Cancer Res. 2013 Dec 01; 73(23):7111-21.
    View in: PubMed
    Score: 0.004
  25. Multiplexed specific label-free detection of NCI-H358 lung cancer cell line lysates with silicon based photonic crystal microcavity biosensors. Biosens Bioelectron. 2013 May 15; 43:50-5.
    View in: PubMed
    Score: 0.004
  26. Isolation of a yeast artificial chromosome clone that spans the (12;16) translocation breakpoint characteristic of myxoid liposarcoma. Cancer Genet Cytogenet. 1992 Sep; 62(2):166-70.
    View in: PubMed
    Score: 0.004
  27. Characterization of the submicroscopic deletion in the small-cell lung carcinoma (SCLC) cell line U2020. Genes Chromosomes Cancer. 1992 Jul; 5(1):67-74.
    View in: PubMed
    Score: 0.004
  28. Putative apolipoprotein receptor gene (LRP, A2MR) is not rearranged in either myxoid liposarcoma or lipomas with translocations in 12q13-14. Cancer Genet Cytogenet. 1992 Jun; 60(2):125-30.
    View in: PubMed
    Score: 0.004
  29. Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination. Invest New Drugs. 2012 Dec; 30(6):2303-17.
    View in: PubMed
    Score: 0.004
  30. Rapid screening of a YAC library by pulsed-field gel Southern blot analysis of pooled YAC clones. Genomics. 1991 Jul; 10(3):661-5.
    View in: PubMed
    Score: 0.004
  31. Report of the Second International Workshop on Human Chromosome 3 mapping. Cytogenet Cell Genet. 1991; 57(4):162-6.
    View in: PubMed
    Score: 0.003
  32. Myxoid liposarcoma with t(12;16) (q13;p11) contains site-specific differences in methylation patterns surrounding a zinc-finger gene mapped to the breakpoint region on chromosome 12. Cancer Res. 1990 Dec 15; 50(24):7902-7.
    View in: PubMed
    Score: 0.003
  33. Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma. BMC Cancer. 2010 Nov 09; 10:619.
    View in: PubMed
    Score: 0.003
  34. A palindrome-mediated recurrent translocation with 3:1 meiotic nondisjunction: the t(8;22)(q24.13;q11.21). Am J Hum Genet. 2010 Aug 13; 87(2):209-18.
    View in: PubMed
    Score: 0.003
  35. The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER. J Cell Biol. 2009 Sep 07; 186(5):685-92.
    View in: PubMed
    Score: 0.003
  36. The tumor suppressor gene TRC8/RNF139 is disrupted by a constitutional balanced translocation t(8;22)(q24.13;q11.21) in a young girl with dysgerminoma. Mol Cancer. 2009 Jul 30; 8:52.
    View in: PubMed
    Score: 0.003
  37. ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells. Neoplasia. 2009 Feb; 11(2):157-66.
    View in: PubMed
    Score: 0.003
  38. A 1.5-megabase restriction map surrounding MYC does not include the translocation breakpoint in familial renal cell carcinoma. Genomics. 1989 Jan; 4(1):28-35.
    View in: PubMed
    Score: 0.003
  39. Chromosomes in solid tumors and beyond. Cancer Res. 1988 Mar 01; 48(5):1049-59.
    View in: PubMed
    Score: 0.003
  40. Construction of long-range restriction maps in human DNA using pulsed field gel electrophoresis. Gene Anal Tech. 1987 Nov-Dec; 4(6):119-31.
    View in: PubMed
    Score: 0.003
  41. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Res. 2007 Sep 15; 67(18):8708-15.
    View in: PubMed
    Score: 0.003
  42. A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma. Genes Chromosomes Cancer. 2007 Sep; 46(9):805-12.
    View in: PubMed
    Score: 0.003
  43. Y chromosome--specific DNA sequences in Turner-syndrome mosaicism. Am J Hum Genet. 1987 Aug; 41(2):157-67.
    View in: PubMed
    Score: 0.003
  44. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res. 2006 May 15; 66(10):5338-45.
    View in: PubMed
    Score: 0.003
  45. DNA demethylation induced by 5-azacytidine does not affect fragile X expression. Am J Hum Genet. 1986 Mar; 38(3):309-18.
    View in: PubMed
    Score: 0.002
  46. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 2006 Jan 15; 66(2):944-50.
    View in: PubMed
    Score: 0.002
  47. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. Neoplasia. 2005 May; 7(5):457-65.
    View in: PubMed
    Score: 0.002
  48. Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics. Leukemia. 2004 Jun; 18(6):1059-63.
    View in: PubMed
    Score: 0.002
  49. WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci U S A. 2003 Sep 02; 100(18):10429-34.
    View in: PubMed
    Score: 0.002
  50. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol. 2002 May 15; 20(10):2417-28.
    View in: PubMed
    Score: 0.002
  51. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer. 2001 Jul 06; 85(1):64-8.
    View in: PubMed
    Score: 0.002
  52. Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A. 2000 Nov 07; 97(23):12776-81.
    View in: PubMed
    Score: 0.002
  53. Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res. 2000 May; 6(5):1616-25.
    View in: PubMed
    Score: 0.002
  54. DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC. Oncogene. 1999 Apr 22; 18(16):2589-97.
    View in: PubMed
    Score: 0.002
  55. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma. Cancer Res. 1998 Oct 15; 58(20):4701-7.
    View in: PubMed
    Score: 0.001
  56. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene. 1998 Jul 30; 17(4):475-9.
    View in: PubMed
    Score: 0.001
  57. An FHIT tumor suppressor gene? Genes Chromosomes Cancer. 1998 Apr; 21(4):281-9.
    View in: PubMed
    Score: 0.001
  58. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997 Sep; 17(1):65-70.
    View in: PubMed
    Score: 0.001
  59. A YAC contig spanning the blepharophimosis-ptosis-epicanthus inversus syndrome and propionic acidemia loci. Eur J Hum Genet. 1997 May-Jun; 5(3):171-4.
    View in: PubMed
    Score: 0.001
  60. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet. 1997 Feb; 6(2):193-203.
    View in: PubMed
    Score: 0.001
  61. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res. 1997 Jan 01; 57(1):1-6.
    View in: PubMed
    Score: 0.001
  62. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention. J Cell Biochem Suppl. 1997; 28-29:64-73.
    View in: PubMed
    Score: 0.001
  63. The gene for autosomal dominant cerebellar ataxia type II is located in a 5-cM region in 3p12-p13: genetic and physical mapping of the SCA7 locus. Am J Hum Genet. 1996 Dec; 59(6):1328-36.
    View in: PubMed
    Score: 0.001
  64. Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers. Genes Chromosomes Cancer. 1996 Dec; 17(4):205-14.
    View in: PubMed
    Score: 0.001
  65. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene. 1996 Mar 21; 12(6):1289-97.
    View in: PubMed
    Score: 0.001
  66. Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokers. Chest. 1996 Mar; 109(3 Suppl):26S.
    View in: PubMed
    Score: 0.001
  67. Report of the sixth international workshop on human chromosome 3 mapping 1995. Cytogenet Cell Genet. 1996; 72(4):255-70.
    View in: PubMed
    Score: 0.001
  68. Assignment of the human slow twitch skeletal muscle/cardiac troponin C gene (TNNC1) to human chromosome 3p21.3-->3p14.3 using somatic cell hybrids. Cytogenet Cell Genet. 1996; 75(1):36-7.
    View in: PubMed
    Score: 0.001
  69. Defining the position of the breakpoint of the constitutional t(3;6) occurring in a family with renal cell carcinoma. Genes Chromosomes Cancer. 1995 Mar; 12(3):224-8.
    View in: PubMed
    Score: 0.001
  70. Report and abstracts of the fifth international workshop on human chromosome 3 mapping 1994. Ann Arbor, Michigan, May 8-9, 1994. Cytogenet Cell Genet. 1995; 68(3-4):125-46.
    View in: PubMed
    Score: 0.001
  71. Integrated YAC contig containing the 3p14.2 hereditary renal carcinoma 3;8 translocation breakpoint and the fragile site FRA3B. Genes Chromosomes Cancer. 1994 Dec; 11(4):216-21.
    View in: PubMed
    Score: 0.001
  72. Physical and genetic mapping of human chromosome 3 loci containing microsatellite repeats. Chromosome Res. 1994 Nov; 2(6):423-7.
    View in: PubMed
    Score: 0.001
  73. Cytogenetic and fluorescence in situ hybridization studies on sporadic and hereditary tumors associated with von Hippel-Lindau syndrome (VHL). Cancer Genet Cytogenet. 1994 Oct; 77(1):1-13.
    View in: PubMed
    Score: 0.001
  74. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma. Genomics. 1994 Jul 15; 22(2):319-26.
    View in: PubMed
    Score: 0.001
  75. Cloning and characterization of the human t(3;6)(p14;p11) translocation breakpoint associated with hematologic malignancies. Cancer Genet Cytogenet. 1993 Nov; 71(1):15-21.
    View in: PubMed
    Score: 0.001
  76. Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint. Proc Natl Acad Sci U S A. 1993 Sep 15; 90(18):8509-13.
    View in: PubMed
    Score: 0.001
  77. Isolation, characterization, and regional mapping of microclones from a human chromosome 21 microdissection library. Am J Hum Genet. 1992 Aug; 51(2):263-72.
    View in: PubMed
    Score: 0.001
  78. Report of the first international workshop on human chromosome 12 mapping. Cytogenet Cell Genet. 1992; 61(4):243-51.
    View in: PubMed
    Score: 0.001
  79. A 2.5-Mb physical map within 3p21.1 spans the breakpoint associated with Greig cephalopolysyndactyly syndrome. Genomics. 1991 Sep; 11(1):93-102.
    View in: PubMed
    Score: 0.001
  80. Loss of heterozygosity on 3p in a renal cell carcinoma in von Hippel-Lindau syndrome. Cancer Genet Cytogenet. 1989 Jun; 39(2):289-93.
    View in: PubMed
    Score: 0.001
  81. Regional and physical mapping studies characterizing the Greig polysyndactyly 3;7 chromosome translocation, t(3;7)(p21.1;p13). Genomics. 1989 May; 4(4):518-29.
    View in: PubMed
    Score: 0.001
  82. Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytes. Cancer Genet Cytogenet. 1988 Mar; 31(1):69-73.
    View in: PubMed
    Score: 0.001
  83. Loss of common 3p14 fragile site expression in renal cell carcinoma with deletion breakpoint at 3p14. Cancer Genet Cytogenet. 1988 Mar; 31(1):75-82.
    View in: PubMed
    Score: 0.001
  84. The Philadelphia chromosome: a model of cancer and molecular cytogenetics. Cancer Genet Cytogenet. 1986 Mar 15; 21(2):129-46.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.